Arcinova and Sterling Pharma Solutions announce collaboration
Arcinova has announced a new collaboration with Sterling Pharma Solutions, a world leading provider of small molecule API development and manufacturing services to the global pharmaceutical industry.
Arcinova will now have access to Sterling Pharma Solutions’ scale up and pilot plant assets, which will complement our existing facilities. Sterling Pharma Solutions is headquartered in Cramlington, UK and is just 28 miles from our Alnwick site.
The facilities include pilot plant assets ranging from 50lt up to 1300lt capacity, with 5-100kg batch generation capability. The combined service offering will allow Arcinova to ensure technical transfer from grams to 100’s kilogram scale and is designed to ensure an integrated facility to meet clients’ drug substance requirements, from preclinical through to full scale commercial launch phases.
The scale up process will be executed by trained Arcinova personnel, supported by the long-established skills, infrastructure and capacity of Sterling Pharma Solutions. Both Arcinova and Sterling Pharma Solutions are very experienced in the provision of secure sources of supply for technically challenging projects.
Ian Shott CBE, CEO of Arcinova and Investor/Director at Sterling Pharma Solutions said: “I’m delighted that Arcinova and Sterling Pharma Solutions have forged this partnership: by working in collaboration and combining expertise and specialist capabilities, we can offer an even wider ranging service to the global pharmaceutical and biotechnology communities and further strengthen the level of support we offer to our clients.”
Paul Quigley, head of API at Arcinova, said: “This new capability will ensure technical transfer from grams to 100’s kilogram scale – thanks to our collaboration with Sterling Pharma Solutions – which is a hugely exciting development for Arcinova and reflects the increased demand we have seen for our API services.
“In addition, this collaboration demonstrates the strength of North East England’s pharmaceutical sector and our ability to make an impact on a global scale.”
Kevin Cook, CEO at Sterling Pharma Solutions added: “This collaboration brings together complementary capabilities to make the North East of England the right choice for pharmaceutical development, scale-up and commercial manufacture.”
On site at Sterling Pharma Solutions, from left to right: Richard Castledine, API development team leader at Arcinova and Martin Wilmshurst, API development chemist at Arcinova.